SmartNuclide

About:

SmartNuclide is a biopharmaceutical company that develops biological drug products.

Website: https://www.smartnucl.com/

Top Investors: Alphamab Oncology, Oriza Holdings, Longmen Capital, Jiuyou Capital, Kington Capital

Description:

SmartNuclide is dedicated to the discovery, manufacture, and marketing of nuclear medicine diagnostic and therapeutic pharmaceuticals. The company established a number of research and development pathways for radiopharmaceutical medications, including recombinant proteins, imaging, and radiotherapeutic pharmaceuticals.

Total Funding Amount:

133M CNY

Headquarters Location:

Suzhou, Jiangsu, China

Founded Date:

2015-09-25

Contact Email:

info(AT)smartnucl.com

Founders:

Tao Xu

Number of Employees:

11-50

Last Funding Date:

2024-04-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai